abeonatherapeutics.com · 814
Abeona Therapeutics is a biopharmaceutical company focused on developing innovative therapies for rare genetic diseases. Their pipeline includes promising treatments such as pz-cel (prademagene zamikeracel) and ABO-50X. The company recently announced new employee inducement grants and reported positive financial results. Manufacturing of therapies takes place at The Elisa Linton Center for Rare Disease Therapies. Abeona Therapeutics is committed to making a difference in the lives of patients and their families through cutting-edge research and development. With a strong focus on patient advocacy and community engagement, the company is dedicated to improving the quality of life for those affected by rare genetic conditions. For investors and media, Abeona Therapeutics offers comprehensive information on news, events, financial data, and stock performance. Connect with Abeona Therapeutics on social media platforms like Facebook, Twitter, and LinkedIn to stay updated on the latest developments.
